Article
Effectiveness and Safety of Vortioxetine for Major Depressive Disorder in Real-World…
Neuropsychiatric Disease and Treatment · 2022 · Wang G, Xiao L, Ren H, Simonsen K, Ma J, Xu X, Guo P, Wang Z, Bai L, Heldbo Reines E, Hammer-Helmich L
Key facts
| Title | Effectiveness and Safety of Vortioxetine for Major Depressive Disorder in Real-World Clinical Practice: Results from the Single-Arm RELIEVE China Study |
|---|---|
| First author | Wang G, Xiao L, Ren H, Simonsen K, Ma J, Xu X, Guo P, Wang Z, Bai L, Heldbo Reines E, Hammer-Helmich L |
| Journal | Neuropsychiatric Disease and Treatment |
| Published | Aug 30, 2022 |
| DOI | 10.2147/NDT.S358253 |
| Devices mentioned | K142653 |
| Product codes mentioned | MBI |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1